571 related articles for article (PubMed ID: 6229579)
1. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
[TBL] [Abstract][Full Text] [Related]
2. Decreased autologous mixed lymphocyte reaction in myasthenia gravis.
Richards I; Harrison R; Lunt GG; Bowen JG
J Clin Lab Immunol; 1986 May; 20(1):15-21. PubMed ID: 2942690
[TBL] [Abstract][Full Text] [Related]
3. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
[TBL] [Abstract][Full Text] [Related]
4. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes.
Richman DP; Patrick J; Arnason BG
N Engl J Med; 1976 Mar; 294(13):694-8. PubMed ID: 129705
[TBL] [Abstract][Full Text] [Related]
5. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.
Willcox HN; Newsom-Davis J; Calder LR
Clin Exp Immunol; 1984 Oct; 58(1):97-106. PubMed ID: 6236921
[TBL] [Abstract][Full Text] [Related]
6. Thymic lymphocytes in myasthenia gravis.
Birnbaum G; Tsairis P
Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595
[TBL] [Abstract][Full Text] [Related]
7. Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects.
Willcox N; Schluep M; Sommer N; Campana D; Janossy G; Brown AN; Newsom-Davis J
Q J Med; 1989 Nov; 73(271):1071-87. PubMed ID: 2623139
[TBL] [Abstract][Full Text] [Related]
8. The immunological effects of thymectomy in myasthenia gravis.
Scadding GK; Thomas HC; Havard CW
Clin Exp Immunol; 1979 May; 36(2):205-13. PubMed ID: 314366
[TBL] [Abstract][Full Text] [Related]
9. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
[TBL] [Abstract][Full Text] [Related]
10. Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.
Newsom-Davis J; Willcox N; Calder L
N Engl J Med; 1981 Nov; 305(22):1313-8. PubMed ID: 7290153
[TBL] [Abstract][Full Text] [Related]
11. Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor alpha-chain peptides: analysis in relation to age, thymic abnormality, and ethnicity.
Oshima M; Deitiker PR; Mosier DR; Smith RG; Atassi MZ
Hum Immunol; 2005 Jan; 66(1):32-42. PubMed ID: 15620460
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients.
Saito R; Onodera H; Tago H; Suzuki Y; Shimizu M; Matsumura Y; Kondo T; Itoyama Y
J Neuroimmunol; 2005 Dec; 170(1-2):172-8. PubMed ID: 16214223
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis.
Dayan M; Sthoeger Z; Neiman A; Abarbanel J; Sela M; Mozes E
Hum Immunol; 2004 Jun; 65(6):571-7. PubMed ID: 15219376
[TBL] [Abstract][Full Text] [Related]
14. B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis.
Shinomiya N; Yata J
Clin Exp Immunol; 1981 Nov; 46(2):277-85. PubMed ID: 6978218
[TBL] [Abstract][Full Text] [Related]
15. Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.
Engleman EG; Benike CJ; Hoppe RT; Kaplan HS; Berberich FR
J Clin Invest; 1980 Jul; 66(1):149-58. PubMed ID: 6447164
[TBL] [Abstract][Full Text] [Related]
16. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.
Leprince C; Cohen-Kaminsky S; Berrih-Aknin S; Vernet-Der Garabedian B; Treton D; Galanaud P; Richard Y
J Immunol; 1990 Oct; 145(7):2115-22. PubMed ID: 2144544
[TBL] [Abstract][Full Text] [Related]
17. [The regulation of anti-acetylcholine receptor antibody production by T cells responding in autologous mixed lymphocyte reaction in patients with myasthenia gravis].
Chiu HC; Hung TP; Hsieh KH
Taiwan Yi Xue Hui Za Zhi; 1987 Apr; 86(4):422-6. PubMed ID: 2955077
[No Abstract] [Full Text] [Related]
18. In vitro T-cell dependent B-cell activity in myasthenia gravis.
Limburg PC; Hummel-Tappel E; Oosterhuis HJ; The TH
Clin Exp Immunol; 1985 Jul; 61(1):31-8. PubMed ID: 3876181
[TBL] [Abstract][Full Text] [Related]
19. [Thymic lymphoid hyperplasia of myasthenia gravis patients: correlation with clinical features and efficacy of thymectomy].
Yoshitake T; Takahama T; Kanai F; Ohnishi K; Tamura K; Suzuki T; Kametani Y; Kataoka D; Nakata H; Itoyama S
Kyobu Geka; 1995 Jun; 48(6):447-51. PubMed ID: 7602854
[TBL] [Abstract][Full Text] [Related]
20. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
Reinhardt C; Melms A
Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
